Is Glycoantigen 125 greater than 200 U/ml an early stage of cancer?

Glycoantigen 125 greater than 200U/ml alone cannot diagnose cancer. Elevated levels are commonly seen in ovarian cancer, endometrial cancer, adenomyosis, chocolate cysts, etc., which need to be combined with the patient’s symptoms, and imaging and biopsy should be performed to clarify the specific cause of the disease.
Glycoantigen 125, with a normal reference range of <35U/ml, is the preferred marker for ovarian cancer and endometrial cancer, and is commonly used in early diagnosis, observation of therapeutic effect, prognosis judgment, and monitoring of recurrence and metastasis of ovarian cancer. Besides ovarian cancer and endometrial cancer, elevated Glycoantigen 125 is also commonly found in endometriosis, uterine fibroids, pelvic inflammatory disease and cirrhosis of the liver. Cancer diagnosis needs to be combined with patient's symptoms, common symptoms of ovarian cancer include abdominal mass, abdominal pain, etc. Endometrial cancer is common with vaginal bleeding, fluid discharge, abdominal pain, etc. Imaging examination such as CT is needed to clarify the presence of mass, and biopsy is needed to make a clear diagnosis if necessary. Glycoantigen 125 greater than 200U/ml is obviously elevated, and it is recommended that the patient should pay attention to it, consult a doctor immediately, further improve the examination to clarify the cause of the disease, and then treat the symptoms.